CompareMarketResearchRequest a sample
Home / Healthcare / Flow Cytometry

Healthcare · Market report

Flow Cytometry Market Size, Share and Forecast 2026-2036

The global flow cytometry market is worth USD 5.7 bn in 2026 and is forecast to reach USD 11.8 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Reagents and consumables is the largest by product segment.

USD 5.7 bnMarket size 2026
USD 11.8 bnForecast 2036
7.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global flow cytometry market is worth USD 5.7 bn in 2026 and is forecast to reach USD 11.8 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Reagents and consumables is the largest by product segment.

ScopeInstruments, reagents, consumables, software and services for flow cytometry, which counts and sorts cells by light scatter and fluorescence, sold to research labs, hospitals, pharma and biotech.
IndustryHealthcare
Value 2025USD 5.3 bn
Value 2026USD 5.7 bn
Value 2036USD 11.8 bn
CAGR 2026-20367.5%
Volume 2026961 million tests
Volume 20361,792 million tests
Average price 2026USD 5.95 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Flow Cytometry market size and forecast, 2026-2036

Exhibit 1The global flow cytometry market is forecast to grow from USD 5.7 bn in 2026 to USD 11.8 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 7.5%
Flow Cytometry market value, 2025 to 2036Market value by year. 2025: USD 5.3 bn; 2026: USD 5.7 bn; 2027: USD 6.1 bn; 2028: USD 6.6 bn; 2029: USD 7.1 bn; 2030: USD 7.6 bn; 2031: USD 8.2 bn; 2032: USD 8.8 bn; 2033: USD 9.5 bn; 2034: USD 10.2 bn; 2035: USD 11.0 bn; 2036: USD 11.8 bn. Compound annual growth rate 2026 to 2036: 7.5%.20255.7 bn20268.2 bn203111.8 bn20367.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 5.7 bn
2027USD 6.1 bn
2028USD 6.6 bn
2029USD 7.1 bn
2030USD 7.6 bn
2031USD 8.2 bn
2032USD 8.8 bn
2033USD 9.5 bn
2034USD 10.2 bn
2035USD 11.0 bn
2036USD 11.8 bn

Flow Cytometry market segmentation

By product

Exhibit 2Reagents and consumables is the largest segment by product, with 52.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Flow Cytometry market share by product, 2026Share of 2026 revenue by product. Reagents and consumables: 52.0%; Instruments: 32.0%; Software: 8.0%; Services: 8.0%.Reagents and consumables52.0%Instruments32.0%Software8.0%Services8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Reagents and consumables52.0%52.9%USD 3.0 bn7.7%
Instruments32.0%29.7%USD 1.8 bn6.7%
Software8.0%9.5%USD 457 mn9.4%
Services8.0%7.9%USD 457 mn7.4%

By application

Exhibit 3Research and drug discovery adds the most revenue by application, growing from USD 2.5 bn in 2026 to USD 4.9 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Flow Cytometry market by application, 2026 and 2036Revenue by application in 2026 and 2036. Research and drug discovery: USD 2.5 bn in 2026, USD 4.9 bn in 2036, change +97%; Clinical diagnostics: USD 1.9 bn in 2026, USD 4.0 bn in 2036, change +104%; Cell and gene therapy: USD 686 mn in 2026, USD 1.9 bn in 2036, change +174%; Industrial and other: USD 571 mn in 2026, USD 986 mn in 2036, change +73%.20262036 forecastChangeResearch and drug discovery+97%2.5 bn4.9 bnClinical diagnostics+104%1.9 bn4.0 bnCell and gene therapy+174%686 mn1.9 bnIndustrial and other+73%571 mn986 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Research and drug discovery44.0%42.0%USD 2.5 bn7.0%
Clinical diagnostics34.0%33.7%USD 1.9 bn7.4%
Cell and gene therapy12.0%15.9%USD 686 mn10.6%
Industrial and other10.0%8.4%USD 571 mn5.6%

By instrument technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Conventional analysers52.0%46.0%USD 3.0 bn6.2%
Spectral analysers14.0%22.0%USD 800 mn12.5%
Imaging cytometers10.0%10.0%USD 571 mn7.5%
Cell sorters24.0%22.0%USD 1.4 bn6.6%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Academic and research institutes30.0%28.0%USD 1.7 bn6.8%
Pharma and biotech28.0%29.0%USD 1.6 bn7.9%
Hospitals and clinical laboratories26.0%26.0%USD 1.5 bn7.5%
Contract research organisations16.0%17.0%USD 914 mn8.2%

By parameter capacity

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Low parameter20.0%12.0%USD 1.1 bn2.1%
Mid parameter46.0%42.0%USD 2.6 bn6.5%
High parameter34.0%46.0%USD 1.9 bn10.8%

Top 25 countries for flow cytometry by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.5%.

Exhibit 4United States is the largest country market at USD 2.2 bn in 2026, and the three largest countries hold 58.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Flow Cytometry market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.2 bn, 38.0%; China: USD 743 mn, 13.0%; Germany: USD 400 mn, 7.0%; Japan: USD 343 mn, 6.0%; United Kingdom: USD 286 mn, 5.0%; France: USD 229 mn, 4.0%; Canada: USD 171 mn, 3.0%; South Korea: USD 171 mn, 3.0%; Italy: USD 143 mn, 2.5%; India: USD 143 mn, 2.5%.United States2.2 bn 38.0%China743 mn 13.0%Germany400 mn 7.0%Japan343 mn 6.0%United Kingdom286 mn 5.0%France229 mn 4.0%Canada171 mn 3.0%South Korea171 mn 3.0%Italy143 mn 2.5%India143 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.2 bn38.0%USD 4.3 bn7.0%
2ChinaUSD 743 mn13.0%USD 2.0 bn10.2%
3GermanyUSD 400 mn7.0%USD 730 mn6.2%
4JapanUSD 343 mn6.0%USD 589 mn5.6%
5United KingdomUSD 286 mn5.0%USD 542 mn6.6%
6FranceUSD 229 mn4.0%USD 412 mn6.1%
7CanadaUSD 171 mn3.0%USD 330 mn6.8%
8South KoreaUSD 171 mn3.0%USD 377 mn8.2%
9ItalyUSD 143 mn2.5%USD 259 mn6.1%
10IndiaUSD 143 mn2.5%USD 412 mn11.2%
11SpainUSD 70 mn1.2%USD 139 mn7.1%
12AustraliaUSD 70 mn1.2%USD 139 mn7.1%
13BrazilUSD 60 mn1.1%USD 148 mn9.5%
14NetherlandsUSD 50 mn0.9%USD 99 mn7.1%
15SwitzerlandUSD 50 mn0.9%USD 99 mn7.1%
16TaiwanUSD 50 mn0.9%USD 99 mn7.1%
17MexicoUSD 40 mn0.7%USD 99 mn9.5%
18BelgiumUSD 40 mn0.7%USD 79 mn7.0%
19SwedenUSD 40 mn0.7%USD 79 mn7.0%
20SingaporeUSD 40 mn0.7%USD 99 mn9.5%
21RussiaUSD 30 mn0.5%USD 60 mn7.3%
22TurkeyUSD 30 mn0.5%USD 74 mn9.6%
23IsraelUSD 30 mn0.5%USD 60 mn7.3%
24DenmarkUSD 30 mn0.5%USD 60 mn7.3%
25PolandUSD 30 mn0.5%USD 60 mn7.3%
Rest of worldUSD 257 mn4.5%USD 526 mn7.4%
Exhibit 5United States and China account for 54% of the USD 6.1 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Flow Cytometry market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 5.7 bn. United States: +USD 2.1 bn; China: +USD 1.2 bn; Germany: +USD 330 mn; India: +USD 269 mn; United Kingdom: +USD 256 mn; 20 other countries: +USD 1.6 bn; Rest of world: +USD 269 mn. Market value 2036: USD 11.8 bn.Market value 20265.7 bnUnited States+2.1 bnChina+1.2 bnGermany+330 mnIndia+269 mnUnited Kingdom+256 mn20 other countries+1.6 bnRest of world+269 mnMarket value 203611.8 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Becton Dickinson
  • Beckman Coulter
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Sysmex
  • Merck KGaA

Group 2: Regional and specialist players

  • Bio-Rad Laboratories
  • Sartorius
  • Miltenyi Biotec
  • Sony Biotechnology
  • DiaSorin
  • Apogee Flow Systems
  • Union Biometrica
  • Mindray

Group 3: Emerging and niche players

  • Cytek Biosciences
  • Stratedigm
  • NanoCellect Biomedical
  • Cytonome/ST
  • Slingshot Biosciences

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the flow cytometry market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.

The market is divided by product, by application, by instrument technology, by end user, by parameter capacity. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the flow cytometry market?

The global flow cytometry market is estimated at USD 5.3 bn in 2025 and USD 5.7 bn in 2026.

How fast will the flow cytometry market grow?

It is forecast to reach USD 11.8 bn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 6.1 bn.

Which country is the largest market for flow cytometry?

United States is the largest market by revenue at USD 2.2 bn in 2026, 38.0% of the global total. The three largest countries together hold 58.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 11.2% a year from 2026 to 2036.

Which flow cytometry segment is largest?

In the by product split, Reagents and consumables is the largest segment with 52.0% of 2026 revenue.

Who are the leading flow cytometry companies?

Global leaders include Becton Dickinson, Beckman Coulter, Thermo Fisher Scientific, Agilent Technologies.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Filtration Membrane Fluid Bed Dryer →

All Healthcare markets →

Request a sample